Why Is MedTech Firm Avinger Stock Trading Higher Today?
Portfolio Pulse from Vandana Singh
Avinger Inc's stock is trading higher following the full commercial launch of its Tigereye ST next-generation image-guided chronic total occlusion (CTO) crossing system. The FDA approved the device in April 2023, and it has since been successfully implemented in 11 clinical centers in the U.S. The device features high definition, real-time intravascular imaging and is designed to assist in steerability within the lumen.
September 18, 2023 | 2:56 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avinger's stock is trading higher due to the successful full commercial launch of its Tigereye ST device. The device's successful implementation and unique features are likely to boost the company's market position.
The news of the full commercial launch of Avinger's Tigereye ST device is directly impacting the company's stock price. The successful implementation of the device in clinical centers and its unique features are likely to enhance the company's market position and increase investor confidence, leading to a rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100